Todd Brady - Profile and Investment Details

Investor Profile

Todd Brady is a Venture Capital, Private Equity Firm based in Rockville, Maryland, United States with a diverse investment portfolio that includes companies such as F2G, UNUM Therapeutics, Avidity Biosciences, Avrobio, Precision BioSciences, Therabron, ReViral, HotSpot Therapeutics, Tyrogenex, Zymeworks, Navitor Pharmaceuticals, Pipeline Therapeutics, Antiva Biosciences, Viridian Therapeutics, . Over time, Todd Brady has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Todd Brady is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Women Founded, Life Science, Biotechnology, Genomics, Medical, Therapeutics, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Todd Brady, as their portfolio suggests a familiarity and interest in this area.

Understanding Todd Brady’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.